Dipharma Francis S.r.l. completes acquisition of Kalexsyn, Inc.
Olivier Geinoz, CEO of Dipharma Francis S.r.l. (second from left), with the Kalexsyn's founders, Robert Gadwood (first from left) and David Zimmermann (third from left).
Milan, Italy – Dipharma Francis S.r.l., (Dipharma), a leading European manufacturer
of Active Pharmaceutical Ingredients, is pleased to communicate that it has completed
its previously announced acquisition of Kalexsyn, Inc. (Kalexsyn), a
world-class Contract Research Organization (CRO) providing chemistry services
to the biotechnology and pharmaceutical industry.
Pursuant to an agreement dated March 19,
2018, Dipharma has acquired all of the issued and outstanding shares of
Kalexsyn through its American subsidiary Dipharma, Inc.
Kalexsyn, based in Kalamazoo, Michigan (USA), was founded in 2003 and provides
chemistry services that support the drug discovery and development activities
of their customers.
About Dipharma
Francis S.r.l.
With revenues exceeding USD 125 million, Dipharma is one of the leading
family-owned European manufacturers of Active Pharmaceutical Ingredients. Its
three manufacturing sites located in northern Italy have been successfully inspected
by the major health authorities since 1970. The Company develops innovative chemical
processes and crystalline forms for the most renowned pharmaceutical companies
in USA, Europe, Japan, and other regions of the globe. Its manufacturing
facilities supply from laboratory to industrial quantities whilst complying
fully with the most stringent quality standards.
About Kalexsyn,
Inc.
Kalexsyn is a world-class chemistry CRO, whose scientists average 15
years’ experience in hit validation, lead optimization and solving tough
synthetic problems. It provides stable label synthesis, custom synthesis,
process impurity synthesis, and process route development to its world-wide
clients. Kalexsyn offers an outstanding CRO experience with fixed quote as well
as short and long-term FTE arrangements. The Company has research laboratories
in Kalamazoo, Michigan.
For
more information:
Paola Clerici
Communication
Manager
Dipharma Francis S.r.l.
Tel. +39 0238228320
[email protected]
www.dipharma.com
